Antibiotic developed 50 years ago may be the key to fighting 'superbugs'
Tuesday, June 24, 2014 - 10:01
in Health & Medicine
Novel dosing regimens for polymyxin combinations to maximize antibacterial activity and to minimize the emergence of resistance and toxicity -- this has been the focus of a recent research study. Developed more than 50 years ago, polymyxins were not subject to modern antibiotic drug development standards. And they have proved to be toxic to both the kidneys and nervous system.